Valuation: ALTEOGEN Inc.

Market Cap 17,729B 11.58B 10.12B 9.33B 8.65B 16.47B 1,105B 16.65B 112B 43.42B 542B 43.51B 42.55B 1,883B P/E 2026 *
60.6x
P/E 2027 * 40.6x
Enterprise Value 17.23B 11.25M 9.84M 9.06M 8.41M 16.01M 1.07B 16.18M 108M 42.2M 527M 42.28M 41.35M 1.83B EV / Sales 2026 *
36.8x
EV / Sales 2027 * 25.1x
Free-Float
74.26%
Yield 2026 *
0.15%
Yield 2027 * 0.16%
1 day-3.07%
1 week-3.64%
Current month-8.31%
1 month-0.45%
3 months-9.44%
6 months-29.35%
Current year-26.36%
1 week 325,000
Extreme 325000
381,500
1 month 286,000
Extreme 286000
397,500
Current year 286,000
Extreme 286000
529,000
1 year 286,000
Extreme 286000
569,000
3 years 38,000
Extreme 38000
569,000
5 years 27,875
Extreme 27875
569,000
10 years 3,645.83
Extreme 3645.8333
569,000
Manager TitleAgeSince
Chief Executive Officer 60 2025-12-25
Director of Finance/CFO 61 2023-03-27
Corporate Officer/Principal - -
Director TitleAgeSince
Chairman 71 2008-05-12
Director/Board Member 70 2021-03-28
Director/Board Member 61 2023-03-27
Date Insider Type Main position Quantity % Market Cap.
25-05-20Fiscal year

Chief Executive Officer

7,200 0.0135%
24-03-26Sell 1,600,000 3.0182%
24-01-04Sell 6,000 0.0115%
Change 5-day change 1-year change 3-year change Capi.($)
-3.07%-3.64%-11.85%+704.37% 11.95B
-0.68%+2.67%+18.72%-9.48% 66.56B
-1.97%-1.59%+50.62%+218.16% 56.51B
-1.13%+40.50%+40.50%+40.50% 42.98B
+1.99%+8.15%-48.83%-54.69% 40.46B
-3.54%-3.50%+56.89%-27.08% 31.91B
+2.56%+21.60%+168.28%-33.79% 31.65B
-1.06%+1.64%+68.91%+83.55% 23.35B
+3.08%+20.43%+4.99%+186.85% 19.46B
+0.21%+2.96%+66.67%+129.01% 17.18B
Average -0.00%+7.34%+41.49%+123.74% 34.2B
Weighted average by Cap. -0.12%+7.13%+40.12%+74.60%

Financials

2026 *2027 *
Net sales 469B 306M 268M 247M 229M 435M 29.21B 440M 2.95B 1.15B 14.34B 1.15B 1.12B 49.78B 672B 439M 384M 354M 328M 624M 41.89B 631M 4.23B 1.65B 20.56B 1.65B 1.61B 71.38B
Net income 311B 203M 177M 163M 152M 289M 19.36B 292M 1.95B 761M 9.5B 762M 746M 32.99B 397B 259M 226M 209M 194M 368M 24.72B 372M 2.49B 971M 12.13B 973M 952M 42.11B
Net Debt -499B -326M -285M -262M -243M -463M -31.09B -468M -3.14B -1.22B -15.26B -1.22B -1.2B -52.97B -828B -540M -473M -435M -404M -769M -51.58B -777M -5.21B -2.03B -25.31B -2.03B -1.99B -87.89B
Logo ALTEOGEN Inc.
Alteogen Inc is a Korea-based company primarily engaged in the research, development, and sales of biopharmaceuticals. The Company develops, produces, and sells biopharmaceuticals, including biobetters and novel biopharmaceuticals, based primarily on hyaluronidase protein engineering technology, sustained-release biopharmaceutical technology, and next-generation antibody-drug conjugate technology. In addition, the Company is engaged in research, development, and commercialization of biosimilars.
Employees
172
Date Price Change Volume
26-07-06 ₩331,000.00 -3.07% 266,040
26-07-03 ₩341,500.00 -2.84% 439,497
26-07-02 ₩351,500.00 -1.82% 392,958
26-07-01 ₩358,000.00 -0.83% 439,869
26-06-30 ₩361,000.00 -3.22% 432,302
Trader
Investor
Global
Quality
ESG MSCI
CCC
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
5
Last Close Price
331,000.00KRW
Average target price
458,000.00KRW
Spread / Average Target
+38.37%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. A196170 Stock